The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of ...

The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed ... United States — argued that ...

AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

Novo Nordisk CEO faces Senate showdown over high prices for diabetes and weight loss drugs Ozempic and Wegovy.

Related FDA approves FluMist for upcoming flu season FTC sues prescription drug middlemen, alleging they conspired over high ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Less than two years ago, neighbors near Brush Creek Boulevard and Troost Avenue had choices when they needed to pick up a ...

Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...

Anthony Fields has owned Lantz’s Pharmacy and Gifts in Stephens City since 2017. He has decided to close the pharmacy portion ...